John Oyler Sells BeOne Medicines Shares

John Oyler, Chief Executive Officer and Director of BeOne Medicines Ltd. (ONC), reported the sale of 3,820 American Depositary Shares (ADS) on June 8, 2026, for an aggregate price of $1,032,570.14. The sale was conducted at a weighted average price of $270.38 per share, with individual transactions ranging from $269.89 to $270.86. This transaction was part of a mandatory tax withholding for a restricted share unit award. An additional 1,120 ADS were sold at a weighted average price of $271.14 per share, with prices ranging from $270.98 to $271.24, for a total of $304,077.92. Following these transactions, Oyler directly owns 0 ADS. Indirect ownership details are extensive, with significant holdings in Ordinary Shares through various trusts and entities, including the P&O Trust, a grantor retained annuity trust, Oyler Investment LLC, a Roth IRA PENSCO trust account, and The John Oyler Legacy Trust. The total number of Ordinary Shares held indirectly and directly is substantial, with direct holdings of 5,545,055 Ordinary Shares.